Elite Pharmaceuticals (ELTP) News Today → What is the 72-Hour Profit Surge? (From DTI) (Ad) Free ELTP Stock Alerts $0.13 0.00 (0.00%) (As of 04/25/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineElite Pharmaceuticals, Inc. (ELTP)finance.yahoo.com - April 17 at 7:22 PMElite Pharmaceuticals, Inc. (PNK:ELTP) Q3 2024 Earnings Call Transcriptfinance.yahoo.com - February 16 at 1:11 PMElite Pharmaceuticals Inc Reports Significant Revenue and Operating Profit Growth in Q3 Fiscal 2024finance.yahoo.com - February 14 at 10:27 PMElite Pharmaceuticals, Inc. Reports Financial Results for Third Quarter of Fiscal Year 2024 ended December 31, 2023 and Provides Conference Call Informationfinance.yahoo.com - February 14 at 5:26 PMElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2024 Financial Results on February 15, 2024finance.yahoo.com - February 8 at 1:11 PMElite Pharmaceuticals (OTCMKTS:ELTP) Stock Price Crosses Above Fifty Day Moving Average of $0.16marketbeat.com - February 6 at 4:17 AMElite Pharmaceuticals, Inc.thestreet.com - January 15 at 7:42 AMElite Pharmaceuticals Files ANDA with US FDA to Market Central Nervous System Stimulantfinance.yahoo.com - December 26 at 7:31 AMElite Pharmaceuticals makes first product shipment of generic Adderall XR to Prascomsn.com - December 12 at 8:33 AMElite Pharmaceuticals Announces First Product Shipment of Generic Adderall XR(R) to Marketing Partner Prasco, LLCfinance.yahoo.com - December 12 at 8:33 AMElite Pharmaceuticals Inc ELTPmorningstar.com - November 24 at 11:15 PMElite Pharmaceuticals, Inc. (PNK:ELTP) Q2 2024 Earnings Call Transcriptfinance.yahoo.com - November 20 at 6:07 PMElite Pharmaceuticals reports Q3 resultsmsn.com - November 14 at 9:34 PMElite Pharmaceuticals, Inc. Reports Financial Results for Second Quarter of Fiscal Year 2024 ended September 30, 2023 and Provides Conference Call Informationfinance.yahoo.com - November 14 at 9:34 PMElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2024 Financial Results on November 15, 2023finance.yahoo.com - November 10 at 2:54 PMElite Pharmaceuticals Files ANDA with US FDA to Market Opiate Analgesic Productfinance.yahoo.com - September 25 at 10:13 AMElite Pharmaceuticals reappoints Carter Ward as CFOmsn.com - September 7 at 2:36 PMElite Pharmaceuticals, Inc. Appoints Carter Ward as Chief Financial Officerfinance.yahoo.com - September 7 at 6:54 AMElite Pharmaceuticals, Inc.: Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Studyfinanznachrichten.de - August 28 at 11:12 AMThis Week's Top OTC Nano-Caps (ATVK, ELTP, EBET, ENZC)benzinga.com - August 28 at 6:12 AMDiscover the Potential: "Top Penny Stocks to Watch Now": SNNC, TIVC, ENZC, ELTP, CLNVbenzinga.com - August 22 at 6:15 PMElite Pharmaceuticals reports Q1 resultsseekingalpha.com - August 14 at 8:48 PMElite Pharmaceuticals, Inc. Reports Financial Results for First Quarter of Fiscal Year 2024 ended June 30, 2023 and Provides Conference Call Informationfinance.yahoo.com - August 14 at 8:48 PMElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2024 Financial Results on August 15, 2023finance.yahoo.com - August 9 at 12:05 PMElite Pharmaceuticals, Inc. (PNK:ELTP) Q4 2023 Earnings Call Transcriptfinance.yahoo.com - July 2 at 12:33 PMElite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2023 and Provides Conference Call Informationfinance.yahoo.com - June 29 at 7:54 PMELTP - Elite Pharmaceuticals, Inc.finance.yahoo.com - June 23 at 10:22 AMElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Fiscal Year 2023 Financial Results on June 30, 2023finance.yahoo.com - June 22 at 7:58 AMElite Pharmaceuticals, Inc. Appoints Mark Pellegrino as Chief Financial Officerfinance.yahoo.com - May 3 at 8:47 AMTrenbolone Enanthate Market 2023-2030marketwatch.com - April 21 at 9:27 PMElite Pharmaceuticals, Inc.: Elite Pharmaceuticals Files ANDA with US FDA to Market Antimetabolite Productfinanznachrichten.de - April 20 at 8:23 AMElite Pharmaceuticals seeks FDA approval for generic antimetabolite drugmsn.com - April 20 at 8:23 AMElite Pharmaceuticals Files ANDA with US FDA to Market Antimetabolite Productfinance.yahoo.com - April 20 at 8:23 AMELTP Elite Pharmaceuticals, Inc.seekingalpha.com - March 17 at 5:54 PMElite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2023 ended December 31, 2022 and Provides Conference Call Informationfinance.yahoo.com - February 14 at 9:07 PMElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2023 Financial Results on February 15, 2023finance.yahoo.com - February 8 at 10:27 AMElite Pharmaceuticals, Inc.: Elite Pharmaceuticals Files ANDA with US FDA to Market Dopamine Agonistfinanznachrichten.de - December 23 at 11:03 PMElite Pharmaceuticals Files ANDA with US FDA to Market Dopamine Agonistfinance.yahoo.com - December 22 at 9:18 AMElite Pharmaceuticals, Inc. (ELTP) Q2 2023 Earnings Call Transcriptseekingalpha.com - November 15 at 6:46 PMElite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2023 Ended September 30, 2022 and Provides Conference Call Informationfinance.yahoo.com - November 15 at 6:46 PMElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2023 Financial Results on November 15, 2022finance.yahoo.com - November 8 at 7:55 AMElite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Studyfinance.yahoo.com - November 2 at 7:04 PMLisata Therapeutics Inc.wsj.com - September 18 at 4:25 AMElite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2023 ended June 30, 2022, and Provides Conference Call Informationfinance.yahoo.com - August 16 at 1:35 PMElite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2023 Financial Results on August 16, 2022finance.yahoo.com - August 11 at 5:21 PMElite Pharmaceuticals Inc - Stock Valuation ELTPmorningstar.com - July 1 at 11:31 PMElite Pharmaceuticals, Inc.'s (ELTP) CEO Nasrat Hakim on Q4 2022 Results - Earnings Call Transcriptseekingalpha.com - June 30 at 9:27 PMElite Pharmaceuticals reports FY resultsseekingalpha.com - June 29 at 8:22 PMElite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2022 and Provides Conference Call Informationfinance.yahoo.com - June 29 at 8:22 PMElite Pharmaceuticals, Inc.: Elite Pharmaceuticals Receives FDA Approval for Generic Sabrilfinanznachrichten.de - June 29 at 10:18 AM Get Elite Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ELTP and its competitors with MarketBeat's FREE daily newsletter. Email Address Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad)The latest flare-up between Israel and Palestinian militants has sent gold prices surging. Why? Because savvy investors know the endgame of the elites at play… Geopolitical crises breed uncertainty — and gold thrives on uncertainty. See why the elites are pouring billions into gold. ELTP Media Mentions By Week ELTP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ELTP News Sentiment▼0.000.38▲Average Medical News Sentiment ELTP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ELTP Articles This Week▼00▲ELTP Articles Average Week Get Elite Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for ELTP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: CytoDyn News Spyre Therapeutics News CervoMed News Incannex Healthcare News I-Mab News Cybin News GlycoMimetics News Skye Bioscience News Renovaro News Relmada Therapeutics News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:ELTP) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsFed launches fourth dollar overhaulStansberry ResearchBitcoin Rockets To Record High But Buy THIS InsteadParadigm PressBetter than Bitcoin? The Biotech Stock with 46,751% PotentialBehind the MarketsEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest MetalsExposed: 10 CENT Crypto to Explode April 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Elite Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
